13F-HR filed by HealthCor Management, L.P.
HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-15, with 43 holding rows worth $1,833,606,000.
- Accession
- 0001343781-16-000014
- Filer
- CIK 1343781
- Filed
- 2016-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2016
A holdings report, 43 entries on the cover page, a total value of $1,833,606,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,833,608,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 1,500,000 | $149,595,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 1,100,000 | $143,297,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 4,000,000 | $138,400,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 1,000,000 | $122,130,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 1,000,000 | $120,380,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 475,000 | $114,865,000 | thousands by filing date | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 1,150,000 | $93,621,000 | thousands by filing date | |
| AKORN INC | 009728106 | COM | 2,100,000 | $59,819,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 750,000 | $58,350,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 1,000,000 | $57,610,000 | thousands by filing date | call |
| HEALTHSOUTH CORP | 421924309 | COM NEW | 1,450,000 | $56,289,000 | thousands by filing date | |
| QIAGEN NV | N72482107 | COMMON STOCK-FO | 2,500,000 | $54,525,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 496,680 | $41,359,000 | thousands by filing date | |
| HILL ROM HLDGS INC | 431475102 | COM | 815,603 | $41,147,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 214,920 | $38,660,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 684,220 | $37,906,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 2,650,000 | $36,358,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 233,245 | $34,464,000 | thousands by filing date | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 475,000 | $33,255,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 243,490 | $32,652,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 396,030 | $31,417,000 | thousands by filing date | |
| REVVITY INC | 714046109 | COM | 582,500 | $30,535,000 | thousands by filing date | |
| CORINDUS VASCULAR ROBOTICS I | 218730109 | COM | 19,981,655 | $28,574,000 | thousands by filing date | |
| ENVISION HEALTHCARE HLDGS IN | 29413U103 | COM | 1,052,160 | $26,693,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 237,830 | $22,770,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 270,680 | $22,580,000 | thousands by filing date | |
| PRA HEALTH SCIENCES INC | 69354M108 | COM | 526,700 | $21,995,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 450,000 | $20,453,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 257,870 | $19,859,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 288,150 | $16,600,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 200,000 | $15,866,000 | thousands by filing date | call |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 1,325,000 | $15,701,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 211,940 | $15,588,000 | thousands by filing date | |
| INC RESH HLDGS INC | 45329R109 | CL A | 400,000 | $15,252,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 310,000 | $14,090,000 | thousands by filing date | call |
| WATERS CORP COM | 941848103 | Stock | 95,530 | $13,436,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 250,000 | $8,433,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 2,258,300 | $7,859,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 623,100 | $6,530,000 | thousands by filing date | |
| RAPTOR PHARMACEUTICAL CORP | 75382F106 | COM | 1,051,315 | $5,646,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 290,600 | $3,506,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 41,730 | $3,361,000 | thousands by filing date | |
| CONATUS PHARMACEUTICALS INC | 20600T108 | COM | 1,059,200 | $2,182,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001343781-16-000014 | this filing | 2016-08-15 | acceptance time not in the bulk data set |